SCHEMBL22733298

SCHEMBL22733298

O=C1CCC(N2Cc3c(Br)cccc3C2=O)CN1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 6/20 0.49
▸ IKZF3 Q9UKT9 4/20 0.44
▸ IKZF1 Q13422 2/20 0.44
▸ BRD4 O60885 1/20 0.44
▸ TNF P01375 1/20 0.44
▸ IL1B P01584 1/20 0.44
▸ DDB1 Q16531 1/20 0.44
▸ MAPK1 P28482 1/20 0.42
▸ PARP10 Q53GL7 1/20 0.40
▸ PARP11 Q9NR21 1/20 0.40
▸ CSNK1A1 P48729 4/20 0.39
▸ PIM1 P11309 1/20 0.39
▸ CDK5 Q00535 1/20 0.39
▸ ROCK1 Q13464 1/20 0.39
▸ DYRK1A Q13627 1/20 0.39
▸ LRRK2 Q5S007 1/20 0.39
▸ CLK4 Q9HAZ1 1/20 0.39
▸ DYRK1B Q9Y463 1/20 0.39
▸ HTR2B P41595 8/20 0.38
▸ HTR2A P28223 6/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27097876 0.85 CRBN (0.62) CRBNIKZF3IKZF1BRD4TNF
SCHEMBL21480839 0.85 CRBN (0.62) CRBNIKZF3IKZF1BRD4TNF
SCHEMBL21311550 0.85 CRBN (0.49) CRBNIKZF3IKZF1BRD4TNF
SCHEMBL25524508 0.81 CRBN (0.47) CRBNIKZF3IKZF1BRD4TNF
SCHEMBL20652629 0.81 HTR2B (0.53) CRBNIKZF3IKZF1BRD4TNF
SCHEMBL23319245 0.81 CRBN (0.47) CRBNIKZF3IKZF1BRD4TNF
Hydrochloric Acid SCHEMBL31184864 0.80 HTR2B (0.48) CRBNIKZF3IKZF1BRD4TNF
SCHEMBL30659847 0.80 PARP1 (0.49) CRBNMAPK1PARP10PARP11HTR2B
SCHEMBL23959034 0.79 CRBN (0.46) CRBNIKZF3IKZF1BRD4TNF
SCHEMBL20128653 0.79 CRBN (0.62) CRBNIKZF3DDB1HTR2BHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020242960-A1 COMPOUNDS TARGETING PROTEINS AND PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS BIOTHERYX, INC. (US) 2020-12-03 — — WO disclosed
Send feedback